Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Tasso Partners, LLC owns the shares of common stock of Orchestra BioMed Holdings, Inc. (the "Issuer"); Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Lorenzo controls Tasso Capital, LLC. (2) Consists of 2,849,592 shares of common stock held by the Reporting Person, which are beneficially owned by Dana Lorenzo, which is the trustee of GCL Family Trust (the "Trust"), and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (3) The percentage ownership was calculated based on a denominator which is the sum of 56,846,755 shares of Common Stock that the Issuer has advised the Reporting Person were issued and outstanding as of the filing date of this report.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Tasso Partners, LLC owns the shares of common stock Orchestra BioMed Holdings, Inc. (the "Issuer"); Tasso Capital, LLC is the manager which controls Tasso Partners, LLC and Dana Lorenzo controls Tasso Capital, LLC. (2) Shared voting and dispositive power consists of 2,849,592 shares of Common Stock held by the Reporting Person which are beneficially owned by Dana Lorenzo, which is the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (3) Sole voting and dispositive power consists of (i) 219,000 shares of Common Stock owned by the Trust, which are beneficially owned by Dana Lorenzo, the trustee of the Trust and (ii) 30,000 warrants exercisable within 60 days of November 19, 2025, into 30,000 shares of common stock. (4) Aggregate amount beneficially owned consists of (i) 2,849,592 shares of Common Stock held by the Reporting Person, (ii) 219,000 shares of Common Stock owned by the Trust, which are beneficially owned by Dana Lorenzo, the trustee of the Trust and (iii) 30,000 warrants exercisable within 60 days of November 19, 2025, into 30,000 shares of common stock, which are beneficially owned by Dana Lorenzo, the trustee of the Trust, and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. (5) The percentage ownership was calculated based on a denominator which is the sum of 56,846,755 shares of Common Stock that the Issuer has advised the Reporting Person were issued and outstanding as of the filing date of this report.


SCHEDULE 13G



 
Tasso Partners, LLC
 
Signature:/s/ Dana Lorenzo/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC
Name/Title:Dana Lorenzo/Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC
Date:11/19/2025
 
Dana Lorenzo
 
Signature:/s/ Dana Lorenzo
Name/Title:Dana Lorenzo
Date:11/19/2025